drugset / Trial / NCT06143670

A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks

NCT06143670

Completed 159 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this clinical study is to investigate the efficacy of a dentifrice containing 0.454 percent (%) weight by weight (w/w) stannous fluoride (SnF2), on gingivitis treatment and plaque reduction, compared to a regular fluoride dentifrice after 12 weeks twice daily brushing in a population of clinically diagnosed gingivitis without undergoing dental prophylaxis.

Timeline

Start
2023-11-29
Primary completion
2024-03-12
Completion
2024-03-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium fluoride Unknown 0.243 %
Subject stannous fluoride Small molecule 0.454 %

Indications